HCS
INSM icon

Himension Capital (Singapore)’s Insmed INSM Stock Holding History

Himension Capital (Singapore)’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,164
Closed -$1.25M – 140
2025
Q4 		$1.25M Sell
7,164
-1,423
-17% -$260K 0.08% 59
2025
Q3 		$1.24M Buy
+8,587
New +$1.05M 0.08% 66

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Himension Capital (Singapore)'s INSM Position: Q1 2026 in Review

Himension Capital (Singapore) sold out of Insmed (INSM) in Q1 2026, closing a stake of 7,164 shares — an estimated $1.25M sold.

Himension Capital (Singapore) first reported a position in INSM in Q3 2025 and held it in 2 quarters. The position peaked at $1.25M in Q4 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Himension Capital (Singapore) reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Himension Capital (Singapore) sold 7,164 Insmed shares in Q1 2026, an estimated $1.25M.
  • Himension Capital (Singapore) first reported a position in Insmed in Q3 2025 and held it in 2 quarters.
  • Himension Capital (Singapore)'s Insmed position peaked at $1.25M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Himension Capital (Singapore)'s 13F filing for Q1 2026, filed 12 May 2026.